Wakefit IPO GMP Today: Strong Demand Signals Moderate Listing Gains (5 Dec 2025)
Wakefit IPO is one of the most discussed public issues among investors tracking the latest IPO opportunities in December 2025. The issue opens for subscription on 8 December 2025 and closes on 10 December 2025, with a price band of ₹185–₹195 per share. Wakefit aims to raise around ₹1,288.9 crore, which includes a fresh issue of ~₹377.2 crore and an OFS of ~₹911.7 crore. With a minimum lot size of 76 shares, retail investors can enter the IPO with an investment of approximately ₹14,820 at the upper band. The company operates on a strong D2C + omnichannel model, offering mattresses, furniture, bedding and home-furnishings through 125 company-owned stores and 1,500+ multi-brand outlets across India.
Wakefit Financial Overview
Wakefit has been scaling aggressively with improving financials in FY26. For the first half of FY26 (H1 2026), the company reported revenue of ₹724 crore and a net profit of ₹35.5 crore, signaling a turnaround from earlier loss-making years. FY25 revenue stood around ₹1,273–1,305 crore, with EBITDA rising meaningfully due to better cost control and higher offline sales traction. The balance sheet has also strengthened, with total assets rising above ₹1,000 crore and net worth climbing past ₹550 crore by September 2025. Wakefit’s vertically integrated structure, strong brand recognition and expanding offline presence place it in a competitive but growing category within India’s home-and-sleep solutions market.
Wakefit IPO GMP Outlook
The biggest buzz around this issue comes from the Wakefit IPO GMP, which is being reported at around ₹36 per share as of 5 December 2025. This grey-market premium indicates healthy early interest among investors tracking latest IPO GMP trends. If the GMP sustains and is added to the upper issue price of ₹195, the estimated listing price could be around ₹231, implying potential listing gains of 18–19%. While the GMP is positive and signals moderate confidence, it’s important to remember that GMP is unofficial, highly speculative and can change quickly depending on broader market sentiment.
Wakefit Investment Risks
Wakefit’s growth story also brings certain risks investors must note. Despite rapid expansion, the company was loss-making until FY25 and relies heavily on its mattress segment for a large portion of revenue. Raising raw material costs, margin pressure, and the lack of long-term supply contracts could affect profitability. A significant OFS portion in the IPO also means that some early investors will partially exit, which may create selling pressure after listing. Still, the company’s recent return to profitability, strong brand momentum and widening retail footprint position Wakefit favorably for medium-to-long-term growth.
Wakefit IPO Overall Outlook
Wakefit IPO offers a balanced opportunity for investors seeking exposure to a fast-expanding consumer brand. The Wakefit IPO GMP shows moderate optimism, making this a potential candidate for both listing-day traders and long-term investors who believe in India’s growing home-furnishing and mattress market. While short-term gains are possible, the real story may unfold over the next few years as Wakefit accelerates its offline expansion, strengthens its product mix and continues improving profitability. For investors tracking the latest IPO opportunities this season, Wakefit stands out as a strong contender with measured but promising potential.
Disclaimer
This blog is for educational and informational purposes only and should not be considered financial, investment, or trading advice. Stock markets are subject to risks, and past performance does not guarantee future results. Always consult a SEBI-registered financial advisor before making any investment decisions. The companies or stocks mentioned here are included solely for learning and research purposes—not as recommendations. NexGen Trade encourages readers to perform their own analysis and invest responsibly.
Frequently Asked Questions (FAQ)
What is Wakefit’s core business?
Wakefit is a leading home-and-sleep solutions brand specializing in mattresses, furniture, home décor, and related lifestyle products. It operates through a vertically integrated model with strong online and fast-growing offline retail presence.
What are the key financial highlights of Wakefit before the IPO?
Wakefit reported revenue of ₹724 crore and a net profit of ₹35.5 crore in H1 FY26, marking a strong turnaround. FY25 revenue crossed ₹1,273 crore with improving EBITDA margins and a stronger balance sheet.
What is the Wakefit IPO GMP today (5 December 2025)?
The Wakefit IPO GMP is around ₹36 per share, indicating moderate listing gain expectations. GMP suggests an estimated listing price of ~₹231 if it holds, but it remains unofficial and volatile.
What is the Wakefit IPO about?
The Wakefit IPO is a public offering by Wakefit Innovations Ltd., a leading home-and-sleep solutions brand known for mattresses, furniture, and home products. The IPO aims to fund expansion and provide partial exit to investors via OFS.
Is the Wakefit IPO good for listing gains?
Based on the current GMP trends, Wakefit shows potential for 18–19% listing gains. However, actual listing performance can vary depending on market sentiment.
What are the major risks associated with Wakefit IPO?
Key risks include high dependence on the mattress segment, margin pressure from raw material costs, earlier years of losses, and selling pressure from the Offer for Sale (OFS) portion.
Should investors apply for the Wakefit IPO?
The IPO offers balanced opportunity—moderate listing gain potential and solid long-term prospects due to brand strength and offline expansion. Investors with medium-to-long-term outlook may find the IPO attractive.
Is Wakefit financially strong?
Yes, Wakefit turned profitable in FY26 with H1 FY26 revenue of ₹724 crore and net profit of ₹35.5 crore. Its balance sheet has strengthened with net worth above ₹550 crore and total assets over ₹1,000 crore.